Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 24 studies | 33% ± 16% | |
fibroblast | 22 studies | 34% ± 16% | |
endothelial cell of vascular tree | 12 studies | 29% ± 11% | |
vein endothelial cell | 10 studies | 40% ± 21% | |
adipocyte | 8 studies | 26% ± 8% | |
capillary endothelial cell | 6 studies | 42% ± 21% | |
pericyte | 6 studies | 29% ± 10% | |
connective tissue cell | 4 studies | 24% ± 6% | |
smooth muscle cell | 3 studies | 23% ± 9% |
Insufficient scRNA-seq data for expression of COL15A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 13293.29 | 458 / 459 | 98% | 75.46 | 1097 / 1118 |
prostate | 96% | 6541.65 | 236 / 245 | 93% | 40.50 | 465 / 502 |
esophagus | 91% | 9427.74 | 1321 / 1445 | 94% | 54.78 | 172 / 183 |
thymus | 96% | 6416.49 | 628 / 653 | 87% | 38.95 | 528 / 605 |
adrenal gland | 99% | 9606.62 | 256 / 258 | 81% | 34.02 | 186 / 230 |
stomach | 83% | 6392.49 | 297 / 359 | 95% | 71.65 | 271 / 286 |
intestine | 86% | 8712.84 | 828 / 966 | 88% | 48.73 | 463 / 527 |
bladder | 95% | 6460.67 | 20 / 21 | 77% | 36.60 | 387 / 504 |
uterus | 98% | 10545.76 | 166 / 170 | 68% | 29.58 | 310 / 459 |
pancreas | 68% | 2251.70 | 224 / 328 | 96% | 77.85 | 171 / 178 |
skin | 63% | 2784.13 | 1138 / 1809 | 91% | 62.63 | 430 / 472 |
lung | 67% | 2976.71 | 388 / 578 | 80% | 39.16 | 925 / 1155 |
ovary | 92% | 6302.70 | 165 / 180 | 48% | 12.06 | 208 / 430 |
kidney | 57% | 2368.44 | 51 / 89 | 71% | 50.67 | 642 / 901 |
adipose | 100% | 16036.05 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 11218.28 | 1318 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 9482.24 | 841 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 71% | 22.63 | 32 / 45 |
lymph node | 0% | 0 | 0 / 0 | 59% | 23.84 | 17 / 29 |
muscle | 49% | 1852.74 | 392 / 803 | 0% | 0 | 0 / 0 |
liver | 0% | 7.08 | 1 / 226 | 40% | 10.20 | 163 / 406 |
eye | 0% | 0 | 0 / 0 | 20% | 3.31 | 16 / 80 |
brain | 0% | 3.95 | 4 / 2642 | 6% | 1.82 | 44 / 705 |
spleen | 6% | 172.65 | 15 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0001525 | Biological process | angiogenesis |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0007155 | Biological process | cell adhesion |
GO_0030154 | Biological process | cell differentiation |
GO_0005604 | Cellular component | basement membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0005582 | Cellular component | collagen type XV trimer |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0016020 | Cellular component | membrane |
GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
Gene name | COL15A1 |
Protein name | Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV) (Related to endostatin) (Restin-I); Restin-2 (Restin-II); Restin-3 (Restin-III); Restin-4 (Restin-IV)] Collagen type XV alpha 1 chain |
Synonyms | |
Description | FUNCTION: Structural protein that stabilizes microvessels and muscle cells, both in heart and in skeletal muscle. .; FUNCTION: Restin potently inhibits angiogenesis. . |
Accessions | A0A087X0K0 ENST00000375001.8 ENST00000610452.1 P39059 |